Details of the Active Pharmaceutical Ingredient (API)

General Information of API (ID: D01472)
Name
Tenapanor
Synonyms    Click to Show/Hide the Synonyms of This API
Tenapanor; 1234423-95-0; AZD1722; Tenapanor free base; UNII-WYD79216A6; AZD-1722; RDX-5791; WYD79216A6; 1234423-95-0 (free base); 3-((S)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinolin-4-yl)-N-(26-((3-((S)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinolin-4-yl)phenyl)sulfonamido)-10,17-dioxo-3,6,21,24-tetraoxa-9,11,16,18-tetraazahexacosyl)benzenesulfonamide; RDX5791; AZD 1722; RDX 5791; Tenapanor [USAN:INN]; Ibsrela; Tenapanor (USAN/INN); GTPL8449; CHEMBL3304485; SCHEMBL15267600; DTXSID40154016; BDBM381823; BCP24892; BCP28554; EX-A2506; MFCD28386333; Tenapanor; AZD1722; RDX5791; US10272079, Compound 002; US10272079, Compound 180; CS-6273; DB11761; SB19099; BS-14732; HY-15991; N,N'-(10,17,-Dioxo-3,6,21,24-tetraoxa-9,11,16,18-tetraazahexacosane-1,26-diyl)bis(((4S)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinolin-4-yl)benzenesulfonamide); J3.655.031G; D11652; Q17122912; AZD 1722;AZD1722;AZD-1722;RDX5791;RDX 5791;RDX-5791; AZD-1722; AZD 1722; AZD1722; RDX 5791; RDX-5791; RDX5791; 1-[2-[2-[2-[[3-[(4S)-6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl]phenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-3-[4-[2-[2-[2-[[3-[(4S)-6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl]phenyl]sulfonylamino]ethoxy]ethoxy]ethylcarbamoylamino]butyl]urea
Clinical Status
Approved
PubChem CID
71587953
Formula
C50H66Cl4N8O10S2
Canonical SMILES
CN1C[C@H](C2=C(C1)C(=CC(=C2)Cl)Cl)C3=CC(=CC=C3)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C4=CC=CC(=C4)[C@@H]5CN(CC6=C5C=C(C=C6Cl)Cl)C
InChI
1S/C50H66Cl4N8O10S2/c1-61-31-43(41-27-37(51)29-47(53)45(41)33-61)35-7-5-9-39(25-35)73(65,66)59-15-19-71-23-21-69-17-13-57-49(63)55-11-3-4-12-56-50(64)58-14-18-70-22-24-72-20-16-60-74(67,68)40-10-6-8-36(26-40)44-32-62(2)34-46-42(44)28-38(52)30-48(46)54/h5-10,25-30,43-44,59-60H,3-4,11-24,31-34H2,1-2H3,(H2,55,57,63)(H2,56,58,64)/t43-,44-/m0/s1
InChIKey
DNHPDWGIXIMXSA-CXNSMIOJSA-N
   Click to Show/Hide the Molecular Data (Structure/Property) of This API
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=71587953"></iframe>
3D MOL is unavailable 2D MOL
Physicochemical Properties Molecular Weight 1145 Topological Polar Surface Area 235
XlogP 5.1 Complexity 1770
Heavy Atom Count 74 Rotatable Bond Count 29
Hydrogen Bond Donor Count 6 Hydrogen Bond Acceptor Count 14
Full List of Drug Formulations (DFMs) Containing This API
          Tenapanor 50 mg tablet Click to Show/Hide the Full List of Formulation(s):          1 Formulation(s)
             Drug Formulation 1 DFM Info click to show the detail info of this DFM
                   All DIGs    Click to Show/Hide the Full List of DIGs in This DFM
Colloidal Silicon Dioxide; Hypromellose; Low-Substituted Hydroxypropyl Cellulose; Microcrystalline Cellulose; Propyl Gallate; Stearic Acid; Tartaric Acid Powder; Titanium Dioxide; Triacetin
                   Dosage Form Tablet
                   Company Ardelyx
                   DIG(s) with
                   Biological Activity
DIG Name DIG Info Representative Biological Activity of This DIG REF
Stearic acid DIG Info Phosphodiesterase 3A (IC50 = 3.1 uM) [1]
Propyl gallate DIG Info Arachidonate 5-lipoxygenase (Ki = 0.43 uM) [1]
Hydroxypropyl cellulose DIG Info Mephenytoin 4-hydroxylase (EC50 = 89.5 uM) [2]
Hypromellose DIG Info Cytochrome P450 3A5 (IC50 = 19.4 uM) [2]
References
1 The activities of drug inactive ingredients on biological targets. Science. 2020 Jul 24;369(6502):403-413.
2 Mediation of in vitro cytochrome p450 activity by common pharmaceutical excipients. Mol Pharm. 2013 Jul 1;10(7):2739-48.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.